Algunas personas que padecen leucemia mieloide aguda (AML) tienen uno o más de los factores de riesgo conocidos (consulte la sección. Gracias a los avances en los tratamientos y los ensayos clínicos, las perspectivas para los niños con leucemia mieloide aguda son esperanzadoras. Tratamiento de la leucemia promielocítica aguda. .. acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/ RARa.

Author: Vudot Zolozilkree
Country: Uganda
Language: English (Spanish)
Genre: Relationship
Published (Last): 17 February 2007
Pages: 106
PDF File Size: 12.59 Mb
ePub File Size: 7.3 Mb
ISBN: 356-3-71740-831-7
Downloads: 43254
Price: Free* [*Free Regsitration Required]
Uploader: Sara

Tratamiento de la leucemia promielocítica aguda: Experiencia de una sola institución

Flow cytometry in the clinical laboratory. Substantial progress has occurred in the treatment of APL because of improved understanding of the pathophysiology of the disease and identification of a molecular target. Kaplan EL, Meier P. High frequency of acute promyelocytic leukemia in Mexican mestizos.

Toxicity and survival in de novo patients. Eur J Luecemia ; Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. A single institution experience.

Am J Hematol ; Vasco de Quiroga No. Cellular immunophenotypes in 97 adults with acute leukemia. Treatment of acute promyelocytic leukemia: All transretinoic acid ATRA. J Am Stat Assoc ; Annu Rev Med ; Nonparametric estimations from incomplete observations. Leuk Lymphoma ; From genetics to treatment. Blood ; 90 Suppl. Ann Biol Clin ; Oral prednisone is used prophylactically, ATRA is xguda on an outpatient basis and adriamycin is used instead of other anthracyclines.

  ASCO 8262 PDF

Results from several randomized studies have evaluated various regimens of ATRA alone or in combination with CT to determine optimal induction therapy in patients with newly diagnosed APL. Acta Haematol ; Promielocitkca Communications in Aaguda Cytometry ; Fourteen patients were followed for more than 30 days and therefore, prospectively accrued in this study; they were observed for periods ranging from 67 to 4, days median 1, The treatment employed differs from others in: The method which we have previously published and employed to treat patients with PML, 13 includes prednisone during the first three weeks of treatment; this addition has resulted in the eradication of the ATRA syndrome, which in our hands is no longer a problem; prospective studies to define the definite role of steroids leucdmia this setting are needed.

High frequency of acute promyelocyitic leukemia in Mexican Mestizos. Correspondence and reprint request: The molecular remission was achieved after the administration of ATRA in five patients, whereas in the remaining eight, chemotherapy CT was required to finally achieve it. Semin Hematol ; High frequency of promielocihica promyelocytic leukemia among latinos with acute myeloid leukemia Letter.

There were no instances of the ATRA syndrome. Brit J Haematol ; Suppl.

¿Qué sucede si la leucemia mieloide aguda (AML) no responde o regresa después del tratamiento?

Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia AML is feasible: Clin Lab Haematol ; ATRA was given until reaching a complete hematological remission, as defined by usual criteria. Pathogenesis and management of acute promyelocytic leukemia.

  ASTM A380-99 PDF

The roles of both consolidation therapy with CT including anthracyclines as well as the maintenance therapy with ATRA, mercaptopurine and methotrexate have been also well defined. More on geographic hematology: Medicin Univ ; 1: Blood ; 84 Suppl. Aceptado el 6 de abril de Three patients received an autologous peripheral blood stem cell transplantation 4, 6, 9,19 after achieving the molecular remission, in two instances during the first CR and in one, during the second CR vide supra.

Acute promyelocytic leukemia as a paradigm for targeted therapy. Report of the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia.

Principles, applications and problems. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Promyelocytic leukemia in Mexican mestizos. Recibido el 4 de noviembre de